Epigenomics Taps US Medtech Veteran For CEO Role
This article was originally published in Clinica
German-US molecular diagnostics company Epigenomics AG has appointed Gregory Hamilton CEO. Hamilton succeeds Thomas Taapken, who served as both CEO and CFO since 2012. The company said it expects to fill the position of CFO shortly.
Register for our free email digests: